| Dyno Nobel Limited (DNL) ORDINARY FULLY PAID |
Materials |
$5,442 |
Update - Notification of buy-back - DNL
|
19 Feb 2026 8:55AM |
$3.310 |
$3.070 |
fallen by
7.25%
|
|
| MA Financial Group Limited (MAF) ORDINARY FULLY PAID |
Financials |
$1,362 |
Dividend/Distribution - MAF
|
19 Feb 2026 8:55AM |
$11.260 |
$6.990 |
fallen by
37.92%
|
|
| Medical Developments International Limited (MVP) ORDINARY FULLY PAID |
Health Care |
$45 |
FY26 Half Year Announcement
|
19 Feb 2026 8:55AM |
$0.455 |
$0.395 |
fallen by
13.19%
|
|
MVP - Price-sensitive ASX Announcement
Full Release
Key Points
- Positive cashflow from operating activities for FY26 half year.
- Penthrox revenue up by $2.3 million.
- Penthrox volume growth of 26% in the Australian hospital segment.
- Penthrox European volume growth of 10%.
- Expanded PBS Prescriber Bag eligibility to Nurse Practitioners in Australia.
- MAGPIE paediatric study published, supporting Penthrox's paediatric use.
- Health economic study completed demonstrating cost savings with Penthrox.
- Cash balance as of 31 December 2025 was $16.9 million.
- Net loss after tax was $0.2 million for the half year.
- Continued focus on expanding Penthrox's market and regulatory approvals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MA Financial Group Limited (MAF) ORDINARY FULLY PAID |
Financials |
$1,362 |
FY25 Annual Report
|
19 Feb 2026 8:54AM |
$11.260 |
$6.990 |
fallen by
37.92%
|
|
| Medical Developments International Limited (MVP) ORDINARY FULLY PAID |
Health Care |
$45 |
FY26 Half Year Presentation
|
19 Feb 2026 8:54AM |
$0.455 |
$0.395 |
fallen by
13.19%
|
|
MVP - Price-sensitive ASX Announcement
Full Release
Key Points
- Penthrox® volume growth of 26% in Australian hospitals.
- Underlying demand for Penthrox® in Europe up 10%.
- MAGPIE paediatric study strengthens clinical evidence.
- Paediatric label approvals in Europe progressing.
- Health economic study shows cost savings with Penthrox®.
- Operating cash flow improved by $1.0 million.
- Strong balance sheet with $16.9 million cash as of December 2025.
- Group revenue increased by 8% to $21.6 million.
- Pain Management segment revenue up 18%.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Medical Developments International Limited (MVP) ORDINARY FULLY PAID |
Health Care |
$45 |
FY26 Half Year Report (including Appendix 4D)
|
19 Feb 2026 8:54AM |
$0.455 |
$0.395 |
fallen by
13.19%
|
|
MVP - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash flows generated from operating activities was $0.3 million.
- Payments for property, plant and equipment totaled $0.2 million.
- Revenue in the Pain Management segment increased by 18% to $15.4 million.
- Underlying EBIT was a $0.3 million loss, compared to a $0.2 million profit the previous period.
- The Respiratory segment revenue decreased by 10% to $6.2 million.
- Net loss after tax was $0.2 million.
- Net assets decreased slightly to $54.8 million from $55.1 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MA Financial Group Limited (MAF) ORDINARY FULLY PAID |
Financials |
$1,362 |
Appendix 4E
|
19 Feb 2026 8:52AM |
$11.260 |
$6.990 |
fallen by
37.92%
|
|
MAF - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from ordinary activities increased by 36.1% to $1,219.9 million.
- Net profit after tax decreased by 75.1% to $10.4 million.
- Total comprehensive income fell by 62.1%.
- Interim dividend of 6 cents per share was paid on 24 September 2025.
- Proposed final dividend of 14 cents per share.
- Net tangible assets per ordinary share decreased to $1.42.
- Additional disclosures in the annual and directors' reports for 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Invion Limited (IVX) ORDINARY FULLY PAID |
Health Care |
$8 |
Notification regarding unquoted securities - IVX
|
19 Feb 2026 8:52AM |
$0.085 |
$0.078 |
fallen by
8.24%
|
|
| EROAD Limited (ERD) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Information Technology |
$123 |
Capital Change Notice - Issue of Performance Share Rights
|
19 Feb 2026 8:52AM |
$0.765 |
$0.655 |
fallen by
14.38%
|
|
| 88 Energy Limited (88E) ORDINARY FULLY PAID |
Energy |
$43 |
South Prudhoe Prospective Resource Update
|
19 Feb 2026 8:52AM |
$0.021 |
$0.037 |
risen by
76.19%
|
|
88E - Price-sensitive ASX Announcement
Full Release
Key Points
- 88 Energy Limited's South Prudhoe acreage is strategically located south of two of North America's largest oil fields.
- The prospective resource assessment identifies significant multi-zone, multi-million-barrel potential.
- South Prudhoe offers low-risk potential for fast-track development through existing infrastructure.
- Ivishak and Kuparuk prospects are adjacent to major oil fields, enhancing development prospects.
- 88 Energy has expanded its lease area through successful bidding, totaling approximately 52,269 acres.
- The net economic interest for 88 Energy has been calculated at 83.33%, and resources have been adjusted accordingly.
- Competent Person statements affirm the validity of the resource estimates.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Downer EDI Limited (DOW) ORDINARY FULLY PAID |
Industrials |
$5,023 |
HY26 Results Media Release
|
19 Feb 2026 8:51AM |
$7.730 |
$7.590 |
fallen by
1.81%
|
|
DOW - Price-sensitive ASX Announcement
Full Release
Key Points
- EBITA margin increased to 4.6%, exceeding the management target.
- Statutory NPAT rose by 29.8% to $98 million.
- Underlying NPATA grew by 7% to $136.1 million.
- Underlying EBITA increased by 11.2% to $227.1 million.
- Downer continues its portfolio simplification strategy.
- Revenue slightly declined but work-in-hand increased by 8.9%.
- Declared a fully franked interim dividend of 12.9 cps.
- Focus remains on enhancing margins and contract performance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Enero Group Limited (EGG) ORDINARY FULLY PAID |
Communication Services |
$44 |
Half Year Results Investor Presentation
|
19 Feb 2026 8:51AM |
$0.550 |
$0.480 |
fallen by
12.73%
|
|
EGG - Price-sensitive ASX Announcement
Full Release
Key Points
- Enero Group reported a 119% increase in adjusted net profit and EPS for FY26 H1.
- EBITDA grew by 15% and the group saw a reduction in net finance costs.
- An interim dividend of 1.0 cps fully franked was declared with a payout ratio of 39% on adjusted EPS.
- THC Practice showed a 3% growth in EBITDA driven by strong performance in Australian agencies.
- Corporate costs reduced by 22% year-over-year, contributing to an improved EBITDA margin of 10.8%.
- Net cash flow decreased due to contingent consideration payments and restructuring costs.
- Revenue showed a slight decline by 1% due to challenging conditions in the international technology market.
- Enero Group is targeting dividend payments consistent with historical payout ratios of 30% - 50% of adjusted earnings per share.
- Significant effort in cost management and operational excellence helped mitigate revenue decline.
- Orchard and BMF showed strong performance with significant EBITDA and margin improvements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Universal Store Holdings Limited (UNI) ORDINARY FULLY PAID |
Consumer Discretionary |
$633 |
H1 FY26 Results Announcement
|
19 Feb 2026 8:51AM |
$8.390 |
$8.250 |
fallen by
1.67%
|
|
UNI - Price-sensitive ASX Announcement
Full Release
Key Points
- Group sales increased by 14.2% to $209.6 million.
- Gross profit margin expanded by 150 basis points to 62.1%.
- Underlying EBIT grew by 23.2% to $43.6 million.
- Statutory NPAT increased by 150.4% to $28.3 million.
- Declared a fully franked interim dividend of 26.0 cents per share.
- Operated 118 stores as of 31 December 2025.
- Focus on trendy, quality products and customer experience.
- Investments in team and technology for future growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tivan Limited (TVN) ORDINARY FULLY PAID |
Materials |
$680 |
Tivan ANU REECON Presentation
|
19 Feb 2026 8:51AM |
$0.470 |
$0.300 |
fallen by
36.17%
|
|
| MoneyMe Limited (MME) ORDINARY FULLY PAID |
Financials |
$67 |
1H26 Results Investor Presentation
|
19 Feb 2026 8:50AM |
$0.105 |
$0.083 |
fallen by
20.95%
|
|
MME - Price-sensitive ASX Announcement
Full Release
Key Points
- 17% increase in gross revenue to $117 million
- 26% increase in loan book to $1.75 billion
- Statutory NPAT loss improved by 44% to $21.9 million
- Normalized NPAT loss improved to $4.6 million
- Operating cash profit of $9.9 million excluding one-off benefits
- Expanded Autopay and personal loan products with focus on secured lending
- Net credit loss rate reduced to 2.9%
- Achieved Certified B Impact Assessment score of 91.2
- Strengthened data security and ESG initiatives
- Plans for new credit card launch and technology platform enhancements
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sonic Healthcare Limited (SHL) ORDINARY FULLY PAID |
Health Care |
$10,162 |
CEO Presentation Half Year Results to 31 December 2025
|
19 Feb 2026 8:50AM |
$21.240 |
$20.560 |
fallen by
3.20%
|
|
SHL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue growth of 17% to A$5.445 billion.
- Net profit increased by 11% to A$262 million.
- EPS improved by 8%.
- EBITDA guidance for FY 2026 maintained.
- Strong performance in Germany and UK markets.
- Ongoing integration and restructuring in the US.
- Focus on capital management and operational efficiency.
- Interim dividend declared at $0.45, 60% franked.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Enero Group Limited (EGG) ORDINARY FULLY PAID |
Communication Services |
$44 |
Half Year Results Announcement
|
19 Feb 2026 8:49AM |
$0.550 |
$0.480 |
fallen by
12.73%
|
|
EGG - Price-sensitive ASX Announcement
Full Release
Key Points
- Enero Group Limited reported a 15% increase in EBITDA for FY26 H1.
- Net profit and earnings per share rose by 119% compared to FY25 H1.
- Net revenue decreased by 1% due to international technology market challenges.
- EBITDA margins improved from 9.3% to 10.8% through cost management.
- BMF and Orchard reported strong performances with significant EBITDA growth.
- Interim dividend declared at 1.0 cent per share, fully franked.
- Net cash on balance sheet at $23.6 million as of December 31, 2025.
- Strategic leadership changes, including new CEO appointments at Hotwire.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sonic Healthcare Limited (SHL) ORDINARY FULLY PAID |
Health Care |
$10,162 |
Media Release Half Year Results to 31 December 2025
|
19 Feb 2026 8:49AM |
$21.240 |
$20.560 |
fallen by
3.20%
|
|
SHL - Price-sensitive ASX Announcement
Full Release
Key Points
- Sonic Healthcare's revenue increased by 17% to A$5,445 million.
- Net profit rose by 11% to A$262 million.
- EBITDA grew by 10% to A$907 million.
- Maintained full-year FY 2026 earnings guidance.
- Ongoing review and restructuring in the US operations.
- Strong performance in Germany and Switzerland.
- Integration of recent acquisitions progressing well.
- Progressive dividend policy with a 1 cent increase.
- Continued focus on cost control and operational efficiency.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Enero Group Limited (EGG) ORDINARY FULLY PAID |
Communication Services |
$44 |
Dividend/Distribution - EGG
|
19 Feb 2026 8:49AM |
$0.550 |
$0.480 |
fallen by
12.73%
|
|
| Universal Store Holdings Limited (UNI) ORDINARY FULLY PAID |
Consumer Discretionary |
$633 |
Dividend/Distribution - UNI
|
19 Feb 2026 8:49AM |
$8.390 |
$8.250 |
fallen by
1.67%
|
|
| Universal Store Holdings Limited (UNI) ORDINARY FULLY PAID |
Consumer Discretionary |
$633 |
Appendix 4D and H1 FY26 Interim Report
|
19 Feb 2026 8:49AM |
$8.390 |
$8.250 |
fallen by
1.67%
|
|
UNI - Price-sensitive ASX Announcement
Full Release
Key Points
- Universal Store Holdings Limited (UNI) reported a strong financial performance for H1 FY26 with a 14.2% increase in revenue to $209.6 million.
- The company achieved a 22.0% increase in underlying NPAT reaching $28.3 million, compared to H1 FY25.
- UNI opened eight new stores, bringing the total to 118 stores across Australia, including Universal Stores, Perfect Stranger, and THRILLS formats.
- The Group's like-for-like sales growth was 8.7% for Universal Stores and 14.8% for Perfect Stranger.
- Gross margin improved by 150 basis points to 62.1%, driven by a strong product mix and disciplined pricing.
- An interim fully franked dividend of 26.0 cents per share was declared, payable on 27 March 2026.
- The Group maintained a strong cash position of $38.4 million and no bank borrowings by the end of the period.
- Online sales contributed 13.3% of total sales, which was a 10.4% increase from the previous year.
- UNI continues to pursue growth through strategic investments in new store openings and enhancements in team and systems capability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PlaySide Studios Limited (PLY) ORDINARY FULLY PAID |
Communication Services |
$108 |
PlaySide Publishing Signs Dew by MVRX Games
|
19 Feb 2026 8:48AM |
$0.310 |
$0.240 |
fallen by
22.58%
|
|
PLY - Price-sensitive ASX Announcement
Full Release
Key Points
- PlaySide Publishing signs a global agreement with MVRX Games.
- Dew is a 1-2 player co-op adventure platformer.
- Developed by former Coldwood Interactive developers.
- Scheduled for release in CY2028.
- PlaySide handles global publishing and marketing.
- Investment expected in low-to-mid single-digit millions AUD.
- PlaySide to receive a share of net revenue.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Antilles Gold Limited (AAU) ORDINARY FULLY PAID |
Materials |
$44 |
Diesel Supply for Construction of Nueva Sabana Mine, Cuba
|
19 Feb 2026 8:48AM |
$0.012 |
$0.014 |
risen by
16.67%
|
|
| Doctor Care Anywhere Group PLC (DOC) CHESS DEPOSITARY INTERESTS 1:1 |
Health Care |
$50 |
Preliminary Final Report Release Date Announcement
|
19 Feb 2026 8:48AM |
$0.195 |
$0.135 |
fallen by
30.77%
|
|
| Ventia Services Group Limited (VNT) ORDINARY FULLY PAID |
Industrials |
$4,719 |
Ventia MD and Group CEO succession
|
19 Feb 2026 8:47AM |
$5.540 |
$5.710 |
risen by
3.07%
|
|
VNT - Price-sensitive ASX Announcement
Full Release
Key Points
- Dean Banks to step down as Ventia MD & CEO in Q4 2026.
- Joined Ventia in January 2021.
- Led Ventia through ASX and NZX listing in November 2021.
- Ventia experienced significant strategic growth under his leadership.
- Succession planning is underway.
- Board appreciates Dean's contributions and leadership.
- Dean will work with the Board for an orderly transition.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
